Tyler Hall

Tyler Hall is an Analyst at North Peak Capital Management, LLC, a New York–based investment firm that describes its approach as "Public Markets, Private Equity-Style" — applying private-equity-style fundamental diligence to publicly traded securities within a concentrated long/short equity portfolio. In this role, Hall conducts in-depth fundamental research and investment analysis across the firm's sector exposures, which span healthcare, consumer, financials, technology, and industrials.

Before joining North Peak, Hall was a Senior Associate in Global Equities at Citadel, one of the largest multi-strategy hedge funds, where he analyzed public companies and generated sector-specific investment ideas within a long/short equity mandate. Earlier in his career, he worked as an Associate in the Private Equity group at Bain Capital, focusing on the healthcare and consumer-retail sectors, and began his career as a management consultant at Bain & Company.

Hall earned a B.A. in Psychology, *cum laude*, from Harvard University.

North Peak Capital itself traces to a predecessor private-equity entity and was repositioned around 2015 into a long/short equity strategy associated with the Kahan brothers. Public regulatory filings (SEC Form ADV) show the firm managing on the order of ~$1.7 billion in regulatory assets under management as of late 2025, consistent with an established institutional hedge fund rather than an early-stage venture vehicle.

• Public equities, not startups. North Peak runs a concentrated long/short equity book in public markets; the analyst role is fundamental research on listed companies, not venture or angel dealmaking.
• "Private Equity-Style" diligence on public names — deep, fundamentals-driven analysis of a small number of high-conviction positions.
• Sector coverage across healthcare, consumer/retail, financials, technology, and industrials — mirroring Hall's prior healthcare/consumer focus at Bain Capital and Citadel.
• No publicly stated personal investment thesis, check size, or founder-facing criteria could be verified — consistent with an employed hedge-fund analyst rather than a check-writing angel.